Adaptive Biotechnologies Seattle, WA - 98109

Adaptive Biotechnologies is categorized under Biotechnology Products and Services in Seattle, WA .

Adaptive Biotechnologies was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Biotechnology Products and Services business, which does work in the B2B market, and is classified as a Biotechnology Products and Services, under code number 5417114 by the NAICS.

If you are seeking more information, feel free to contact Chad Robins, Chief Executive Officer at the company’s single location by writing to 307 Westlake Avenue North # 300, Seattle, Washington WA 98109 or by phoning (206) 659-0067. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Adaptive Biotechnologies
Contact Person: Chad Robins, Chief Executive Officer
Address: 307 Westlake Avenue North # 300, Seattle, Washington 98109
Phone Number: (206) 659-0067
Annual Revenue (USD): Unknown
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Biotechnology Products and Services
SIC Code: 8731
NAICS Code: 5417114
Share This Business:

Adaptive Biotechnologies was started in 0 to provide professional Biotechnology Products and Services under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Chad Robins, Chief Executive Officer for inquiries that concern Adaptive Biotechnologies by calling the company number (206) 659-0067, as your correspondence is most welcome. Additionally, the physical location of the single location of Adaptive Biotechnologies can be found at the coordinates 47.62129,-122.33854 as well as the street address 307 Westlake Avenue North # 300 in Seattle, Washington 98109.

For its online presence, you may visit Adaptive Biotechnologies’s website at and engage with its social media outlets through on Twitter and on Facebook.